The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Zonisamide-Global Market Insights and Sales Trends 2025
Synopsis
Zonisamide is a medication used to treat the symptoms of epilepsy and Parkinson's disease.
The global Zonisamide market size is expected to reach US$ 718.8 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Zonisamide in various end use industries. The expanding demands from the Adult, Pediatric and Geriatric,, are propelling Zonisamide market. 25mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 50mg segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Zonisamide market, driven by demand from China, the second largest economy with some signs of stabilising, the Zonisamide market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Zonisamide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Zonisamide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Zonisamide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Zonisamide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Zonisamide covered in this report include Concordia, Eisai, Zydus Pharmaceuticals, Sun Pharma, Wockhardt, Mylan, APOTEX, Teva and Glenmark, etc.
The global Zonisamide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals
Global Zonisamide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Zonisamide market, Segment by Type:
25mg
50mg
100mg
Global Zonisamide market, by Application
Adult
Pediatric
Geriatric
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Zonisamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Zonisamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Zonisamide is a medication used to treat the symptoms of epilepsy and Parkinson's disease.
The global Zonisamide market size is expected to reach US$ 718.8 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Zonisamide in various end use industries. The expanding demands from the Adult, Pediatric and Geriatric,, are propelling Zonisamide market. 25mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 50mg segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Zonisamide market, driven by demand from China, the second largest economy with some signs of stabilising, the Zonisamide market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Zonisamide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Zonisamide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Zonisamide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Zonisamide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Zonisamide covered in this report include Concordia, Eisai, Zydus Pharmaceuticals, Sun Pharma, Wockhardt, Mylan, APOTEX, Teva and Glenmark, etc.
The global Zonisamide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals
Global Zonisamide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Zonisamide market, Segment by Type:
25mg
50mg
100mg
Global Zonisamide market, by Application
Adult
Pediatric
Geriatric
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Zonisamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Zonisamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Zonisamide Market Overview
1.1 Zonisamide Product Overview
1.2 Zonisamide Market Segment by Type
1.2.1 25mg
1.2.2 50mg
1.2.3 100mg
1.3 Global Zonisamide Market Size by Type
1.3.1 Global Zonisamide Market Size Overview by Type (2018-2029)
1.3.2 Global Zonisamide Historic Market Size Review by Type (2018-2023)
1.3.3 Global Zonisamide Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Zonisamide Sales Breakdown by Type (2018-2023)
1.4.2 Europe Zonisamide Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Zonisamide Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Zonisamide Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Zonisamide Sales Breakdown by Type (2018-2023)
2 Global Zonisamide Market Competition by Company
2.1 Global Top Players by Zonisamide Sales (2018-2023)
2.2 Global Top Players by Zonisamide Revenue (2018-2023)
2.3 Global Top Players by Zonisamide Price (2018-2023)
2.4 Global Top Manufacturers Zonisamide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Zonisamide Market Competitive Situation and Trends
2.5.1 Zonisamide Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Zonisamide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Zonisamide as of 2022)
2.7 Date of Key Manufacturers Enter into Zonisamide Market
2.8 Key Manufacturers Zonisamide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Zonisamide Status and Outlook by Region
3.1 Global Zonisamide Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Zonisamide Historic Market Size by Region
3.2.1 Global Zonisamide Sales in Volume by Region (2018-2023)
3.2.2 Global Zonisamide Sales in Value by Region (2018-2023)
3.2.3 Global Zonisamide Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Zonisamide Forecasted Market Size by Region
3.3.1 Global Zonisamide Sales in Volume by Region (2024-2029)
3.3.2 Global Zonisamide Sales in Value by Region (2024-2029)
3.3.3 Global Zonisamide Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Zonisamide by Application
4.1 Zonisamide Market Segment by Application
4.1.1 Adult
4.1.2 Pediatric
4.1.3 Geriatric
4.2 Global Zonisamide Market Size by Application
4.2.1 Global Zonisamide Market Size Overview by Application (2018-2029)
4.2.2 Global Zonisamide Historic Market Size Review by Application (2018-2023)
4.2.3 Global Zonisamide Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Zonisamide Sales Breakdown by Application (2018-2023)
4.3.2 Europe Zonisamide Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Zonisamide Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Zonisamide Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Zonisamide Sales Breakdown by Application (2018-2023)
5 North America Zonisamide by Country
5.1 North America Zonisamide Historic Market Size by Country
5.1.1 North America Zonisamide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Zonisamide Sales in Volume by Country (2018-2023)
5.1.3 North America Zonisamide Sales in Value by Country (2018-2023)
5.2 North America Zonisamide Forecasted Market Size by Country
5.2.1 North America Zonisamide Sales in Volume by Country (2024-2029)
5.2.2 North America Zonisamide Sales in Value by Country (2024-2029)
6 Europe Zonisamide by Country
6.1 Europe Zonisamide Historic Market Size by Country
6.1.1 Europe Zonisamide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Zonisamide Sales in Volume by Country (2018-2023)
6.1.3 Europe Zonisamide Sales in Value by Country (2018-2023)
6.2 Europe Zonisamide Forecasted Market Size by Country
6.2.1 Europe Zonisamide Sales in Volume by Country (2024-2029)
6.2.2 Europe Zonisamide Sales in Value by Country (2024-2029)
7 Asia-Pacific Zonisamide by Region
7.1 Asia-Pacific Zonisamide Historic Market Size by Region
7.1.1 Asia-Pacific Zonisamide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Zonisamide Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Zonisamide Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Zonisamide Forecasted Market Size by Region
7.2.1 Asia-Pacific Zonisamide Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Zonisamide Sales in Value by Region (2024-2029)
8 Latin America Zonisamide by Country
8.1 Latin America Zonisamide Historic Market Size by Country
8.1.1 Latin America Zonisamide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Zonisamide Sales in Volume by Country (2018-2023)
8.1.3 Latin America Zonisamide Sales in Value by Country (2018-2023)
8.2 Latin America Zonisamide Forecasted Market Size by Country
8.2.1 Latin America Zonisamide Sales in Volume by Country (2024-2029)
8.2.2 Latin America Zonisamide Sales in Value by Country (2024-2029)
9 Middle East and Africa Zonisamide by Country
9.1 Middle East and Africa Zonisamide Historic Market Size by Country
9.1.1 Middle East and Africa Zonisamide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Zonisamide Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Zonisamide Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Zonisamide Forecasted Market Size by Country
9.2.1 Middle East and Africa Zonisamide Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Zonisamide Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Concordia
10.1.1 Concordia Company Information
10.1.2 Concordia Introduction and Business Overview
10.1.3 Concordia Zonisamide Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Concordia Zonisamide Products Offered
10.1.5 Concordia Recent Development
10.2 Eisai
10.2.1 Eisai Company Information
10.2.2 Eisai Introduction and Business Overview
10.2.3 Eisai Zonisamide Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Eisai Zonisamide Products Offered
10.2.5 Eisai Recent Development
10.3 Zydus Pharmaceuticals
10.3.1 Zydus Pharmaceuticals Company Information
10.3.2 Zydus Pharmaceuticals Introduction and Business Overview
10.3.3 Zydus Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Zydus Pharmaceuticals Zonisamide Products Offered
10.3.5 Zydus Pharmaceuticals Recent Development
10.4 Sun Pharma
10.4.1 Sun Pharma Company Information
10.4.2 Sun Pharma Introduction and Business Overview
10.4.3 Sun Pharma Zonisamide Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sun Pharma Zonisamide Products Offered
10.4.5 Sun Pharma Recent Development
10.5 Wockhardt
10.5.1 Wockhardt Company Information
10.5.2 Wockhardt Introduction and Business Overview
10.5.3 Wockhardt Zonisamide Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Wockhardt Zonisamide Products Offered
10.5.5 Wockhardt Recent Development
10.6 Mylan
10.6.1 Mylan Company Information
10.6.2 Mylan Introduction and Business Overview
10.6.3 Mylan Zonisamide Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Mylan Zonisamide Products Offered
10.6.5 Mylan Recent Development
10.7 APOTEX
10.7.1 APOTEX Company Information
10.7.2 APOTEX Introduction and Business Overview
10.7.3 APOTEX Zonisamide Sales, Revenue and Gross Margin (2018-2023)
10.7.4 APOTEX Zonisamide Products Offered
10.7.5 APOTEX Recent Development
10.8 Teva
10.8.1 Teva Company Information
10.8.2 Teva Introduction and Business Overview
10.8.3 Teva Zonisamide Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Teva Zonisamide Products Offered
10.8.5 Teva Recent Development
10.9 Glenmark
10.9.1 Glenmark Company Information
10.9.2 Glenmark Introduction and Business Overview
10.9.3 Glenmark Zonisamide Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Glenmark Zonisamide Products Offered
10.9.5 Glenmark Recent Development
10.10 Bluepharma
10.10.1 Bluepharma Company Information
10.10.2 Bluepharma Introduction and Business Overview
10.10.3 Bluepharma Zonisamide Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Bluepharma Zonisamide Products Offered
10.10.5 Bluepharma Recent Development
10.11 Invagen Pharmaceuticals
10.11.1 Invagen Pharmaceuticals Company Information
10.11.2 Invagen Pharmaceuticals Introduction and Business Overview
10.11.3 Invagen Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Invagen Pharmaceuticals Zonisamide Products Offered
10.11.5 Invagen Pharmaceuticals Recent Development
10.12 Intas Pharmaceuticals
10.12.1 Intas Pharmaceuticals Company Information
10.12.2 Intas Pharmaceuticals Introduction and Business Overview
10.12.3 Intas Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Intas Pharmaceuticals Zonisamide Products Offered
10.12.5 Intas Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Zonisamide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Zonisamide Industrial Chain Analysis
11.4 Zonisamide Market Dynamics
11.4.1 Zonisamide Industry Trends
11.4.2 Zonisamide Market Drivers
11.4.3 Zonisamide Market Challenges
11.4.4 Zonisamide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Zonisamide Distributors
12.3 Zonisamide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
